Shopping Cart
Remove All
Your shopping cart is currently empty
BL-B01D1 is a bispecific ADC that targets EGFR and HER3 via the bispecific antibody Izalontamab. It exerts cytotoxic effects on various cancer cells by using its ADC toxin ED04 to inhibit DNA replication and synthesis.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | BL-B01D1 is a bispecific ADC that targets EGFR and HER3 via the bispecific antibody Izalontamab. It exerts cytotoxic effects on various cancer cells by using its ADC toxin ED04 to inhibit DNA replication and synthesis. |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.